Detalhe da pesquisa
1.
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
Mult Scler
; 30(7): 820-832, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38551315
2.
Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis.
Mult Scler
; 29(3): 352-362, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36515487
3.
The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
Brain
; 145(11): 3931-3942, 2022 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35727945
4.
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Mult Scler
; 28(7): 1138-1145, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35475363
5.
Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset.
Eur J Neurol
; 29(4): 1075-1081, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33609298
6.
COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response.
Eur J Neurol
; 28(10): 3384-3395, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33340215
7.
Multiple sclerosis management during the COVID-19 pandemic.
Mult Scler
; 26(10): 1163-1171, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32772807
8.
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating Event.
Neurology
; 101(13): e1280-e1292, 2023 09 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37468284
9.
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 9(2)2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35105687